The event includes insights from manufacturers, analysts, policymakers and public health leaders
Compare compound profiles Use this Avion tool to keep researchers moving through the website instead of leaving after one article
Both companies have built extensive patent thickets around their core molecules, with Novo Nordisk in particular pursuing aggressive filing strategies across new formulations, indications, and delivery methods
On average, participants lost 15.1% of their body weight after 68 weeks compared to 2.4% of body weight from those on the placebo
These include GLP-1, GIP, peptide YY, and cholecystokinin (CCK), among others
T., Nagarajan, N